Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation and Evaluation of PIPAC for the Treatment of Patients With Peritoneal Carcinomatosis - a Feasibility Study.

NCT02320448 is registered in ClinicalTrials.gov with Michael Bau Mortensen as lead sponsor.

NCT NCT02320448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02320448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation and Evaluation of PIPAC for the Treatment of Patients With Peritoneal Carcinomatosis - a Feasibility Study.
Lead sponsor
Michael Bau Mortensen
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
August 31, 2017
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal carcinomatosis